Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05578326
Title Study of Trilaciclib and Lurbinectidin
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors UNC Lineberger Comprehensive Cancer Center
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Dartmouth Hitchcock Medical Center WITHDRAWN Lebanon New Hampshire 03756 United States Details
Lineberger Comprehensive Cancer Center at University of North Carolina Chapel Hill RECRUITING Chapel Hill North Carolina 27599 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field